Thompson Siegel & Walmsley LLC Horizon Therapeutics Public LTD CO Transaction History

Thompson Siegel & Walmsley LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$67.0 - $84.39 $301,500 - $379,755	-4,500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $248,535 - $359,685	4,500 New	4,500 $350,000
Q4 2019 Feb 07, 2020	SELL	$25.43 - $36.67 $127,150 - $183,350	-5,000 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$23.0 - $27.97 $207,000 - $251,730	-9,000 Reduced 64.29%	5,000 $136,000
Q2 2019 Aug 12, 2019	BUY	$22.81 - $28.48 $319,340 - $398,720	14,000 New	14,000 $337,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.